Homoeopathy India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.03 M
as on 31-12-2024
- Revenue 43.05%
(FY 2022)
- Profit -4.52%
(FY 2022)
- Ebitda -17.14%
(FY 2022)
- Net Worth 68.82%
(FY 2022)
- Total Assets 72.03%
(FY 2022)
About Homoeopathy India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.03 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rupal Shah and Rajesh Shah serve as directors at the Company.
- CIN/LLPIN
U24234MH2002PTC138180
- Company No.
138180
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Homoeopathy India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Shah  | Whole-Time Director | 01-Apr-2006 | Current |
| Rupal Shah | Director | 09-Dec-2002 | Current |
Financial Performance of Homoeopathy India.
Homoeopathy India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.05% increase. The company also saw a slight decrease in profitability, with a 4.52% decrease in profit. The company's net worth Soared by an impressive increase of 68.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Homoeopathy India?
Unlock access to Homoeopathy India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Life Force Molecules Private LimitedActive 18 years 8 monthsRupal Shah and Rajesh Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Ltd. Creation Date: 18 Feb 2005 | ₹1.03 M | Satisfied |
How Many Employees Work at Homoeopathy India?
Homoeopathy India has a workforce of 48 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Homoeopathy India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Homoeopathy India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
